Ho Chi Minh City Oncology Hospital
WebsiteOverview
Bệnh viện Ung Bướu Thành phố Hồ Chí Minh (Ho Chi Minh City Oncology Hospital) is the largest public specialist cancer hospital in Vietnam and the main tertiary cancer referral centre for the southern region, established in 1985.
The hospital has 2 campuses: the original campus in Bình Thạnh District and a new campus of ~1,000 beds (investment of ~VND 6,000 billion) in Thủ Đức City, fully operational since February 2023, designed to international standards with 18 modern operating theatres.
About 82% of patients come from other provinces and cities, reflecting its position as the leading cancer referral hospital in the southern region.
Scale
Beds: 1,000 (Thủ Đức campus, including a 500-bed inpatient block) + the original campus in Bình Thạnh Cancer cases treated per year: ~37,000 cancer operations per year; >180,000 radiotherapy sessions per year; ~800,000 outpatient visits per year
Accreditation
No JCI accreditation (a public hospital). It is the leading national/regional public cancer referral centre in the southern region.
Strengths and key treatments
A modern radiotherapy centre: 6 linear accelerators with image-guided radiotherapy (IGRT), 2 CT simulators, 2 brachytherapy systems.
AI-assisted radiotherapy planning (RaySearch software) — shortening planning time from ~4 hours to ~2 minutes and patient waiting time from more than 10 days to ~3 days.
PET/CT in operation since December 2019.
High-volume cancer surgery across 18 operating theatres; a rooftop helipad for emergency transport.
Oncologists
Director (appointed in November 2024); specialises in medical oncology.
Deputy Director; known for community communication work on cancer prevention and control.
Head of the Department of Surgery 4 and Chair of the Department of Oncology (University of Medicine and Pharmacy at Ho Chi Minh City); specialises in breast cancer and head, neck and facial cancers.